Spots Global Cancer Trial Database for gallbladder
Every month we try and update this database with for gallbladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | NCT00448786 | Solid Tumors | AMG 706 AMG 706 AMG 706 | 18 Years - | Amgen | |
| Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | NCT00660140 | Cholangiocarcin... Gallbladder Can... | Gemcitabine Carboplatin | 18 Years - | Washington University School of Medicine | |
| Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy | NCT03510923 | Appendix Appendectomy Appendiceal Neo... Gallbladder Cholecystectomy Gallbladder Neo... | Inspection and ... Inspection and ... | - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer | NCT04163900 | Biliary Tract C... | NUC-1031 Gemcitabine Cisplatin | 18 Years - | NuCana plc | |
| A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) | NCT04907851 | Advanced Solid ... | RXC004 RXC004 RXC004 Denosumab pembrolizumab | 18 Years - | Redx Pharma Plc | |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | NCT00123825 | Gallbladder Can... Biliary Tract C... | Gemcitabine Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | NCT00660140 | Cholangiocarcin... Gallbladder Can... | Gemcitabine Carboplatin | 18 Years - | Washington University School of Medicine | |
| A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | NCT00660699 | Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Ampullary Cance... | Gemcitabine Docetaxel Radiation | 18 Years - | Washington University School of Medicine | |
| Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | NCT00448786 | Solid Tumors | AMG 706 AMG 706 AMG 706 | 18 Years - | Amgen | |
| A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer | NCT02908451 | Gastric Cancer Colorectal Canc... Pancreatic Canc... Biliary Cancer | AbGn-107 | 18 Years - | AbGenomics B.V Taiwan Branch | |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | NCT00123825 | Gallbladder Can... Biliary Tract C... | Gemcitabine Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
| A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | NCT00660699 | Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Ampullary Cance... | Gemcitabine Docetaxel Radiation | 18 Years - | Washington University School of Medicine | |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer | NCT00753675 | Biliary Tract C... Gallbladder Can... Cancer Of The E... Ampullary Carci... | ZD6474, Vandeta... ZD6474, Vandeta... Gemcitabine Placebo matchin... | 18 Years - | Sanofi | |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer | NCT00753675 | Biliary Tract C... Gallbladder Can... Cancer Of The E... Ampullary Carci... | ZD6474, Vandeta... ZD6474, Vandeta... Gemcitabine Placebo matchin... | 18 Years - | Sanofi |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
